Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Trinity Biosystems
company
About
Trinity Biosystems develops oral therapeutic proteins and vaccines for respiratory, digestive and sexually transmitted diseases.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2002
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases, as well as transporting proteins, peptides, and other macromolecules. The company was founded in 2002 and is based in Menlo Park, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$22.50M
Trinity Biosystems has raised a total of
$22.50M
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2006 | Series B | $21M | 1 | — | — | Detail |
| Sep 25, 2002 | Series A | $1.50M | 1 |
Tenex Greenhouse Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Trinity Biosystems is funded by 1 investors.
Tenex Greenhouse Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Tenex Greenhouse Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
